眼科医疗业绩

Search documents
普瑞眼科:2025年上半年净利润1466.75万元,同比下降66.12%
Xin Lang Cai Jing· 2025-08-28 08:09
Core Insights - The company reported a revenue of 1.459 billion yuan for the first half of 2025, representing a year-on-year growth of 2.74% [1] - The net profit for the same period was 14.6675 million yuan, showing a significant decline of 66.12% compared to the previous year [1] Financial Performance - Revenue: 1.459 billion yuan, up 2.74% year-on-year [1] - Net Profit: 14.6675 million yuan, down 66.12% year-on-year [1]
光正眼科:2025年上半年净利润同比增长11.38%
Xin Lang Cai Jing· 2025-08-21 10:53
Core Viewpoint - The company reported a decline in operating revenue for the first half of 2025, while net profit showed an increase, indicating mixed financial performance [1] Financial Performance - Operating revenue for the first half of 2025 was 436 million yuan, representing a year-on-year decrease of 9.49% [1] - Net profit for the same period was 1.4189 million yuan, reflecting a year-on-year increase of 11.38% [1]
光正眼科:2025一季报净利润0.01亿 同比增长105.26%
Tong Hua Shun Cai Bao· 2025-04-27 08:07
Financial Performance - The company reported a basic earnings per share of 0.0000 yuan for Q1 2025, a significant improvement from -0.0400 yuan in Q1 2024, marking a 100% increase [1] - Net profit for Q1 2025 was 0.01 billion yuan, compared to a loss of 0.19 billion yuan in Q1 2024, representing a 105.26% increase [1] - Operating revenue for Q1 2025 was 2.08 billion yuan, up 4% from 2 billion yuan in Q1 2024 [1] - The return on equity (ROE) improved to 0.50% in Q1 2025 from -6.84% in Q1 2024, indicating a 107.31% increase [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 15,177.04 million shares, accounting for 29.87% of the circulating shares, with a slight increase of 9.92 million shares from the previous period [1] - The largest shareholder, Guangzheng Investment Co., Ltd., holds 12,916.87 million shares, representing 25.41% of the total share capital, with no change in holdings [2] - New entrants among the top shareholders include Lin Yande, Hao Caiming, and Hao Chengxiang, while Xun Yanhong, Qiu Wanshu, and Luo Wenhua have exited the top ten list [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [3]
光正眼科:2024年净亏损1.75亿元
news flash· 2025-04-23 14:48
光正眼科(002524)公告,2024年营业收入8.93亿元,同比下降16.94%。归属于上市公司股东的净亏损 1.75亿元,去年同期净利润925.5万元。基本每股收益-0.34元/股。公司计划不派发现金红利,不送红 股,不以公积金转增股本。 ...